@osteopatient2026 i’m sorry to say you did not post “why “ you only posted “what” was published.. In none of what you wrote, and in none of my research, could I establish “why”thigh subcutaneous injections were not acceptable. We do not know the science behind the WHY. We only know that they tested on abdominal area subcutaneous injection alone. That answers HOW. Logic dictates that there must be a difference between subcutaneous thigh versus abdominal area injections. Today I have found no difference.. In addition, your rush to judgment is missing some science to conclude that there IS a difference! In one hour, I will meet with the team endocrinologist doctor and I will be asking these questions. if we find out that others injected in their subcutaneous thigh area and had the expected response, then we will have to conclude that there was some other reason for which I wasn’t adequately performing in the first year.

In my case, there are many variables. I had a major double cervical spine surgery, which may have impeded my success the first year on TYMLOS. Also since limited mobility excluded me from accessing my abdominal area, the thigh was recommended. better to do it the thigh area, my doctor recommended then not at all. In addition, maybe that BHRT fully on board after the first year might’ve made the difference in the second year. I presume that the UCSD endocrinology department has pursued this so they wouldn’t recommend something that didn’t work, they are World class and teach the next generations of doctors. but I could be wrong so I will definitely make that a priority in our discussion today.

I do not give the TYMLOS people a huge amount of credit either. Their ability to contact me with science and knowledge based info/doctors was nonexistent. The best I got after months of investigating was a tolerant person who was tasked to call me back from Brazil. Patiently we worked together to only determine that nothing can be concluded when there is no clinical trial that investigated anything but the abdominal subcutaneous area. I will definitely see if I could add more to this puzzle. Like I indicated once before, there was information I had come across in my initial startup with the medication that had indicated that subcutaneous thigh injections were appropriate. When I went back to find that published information there was nothing to be found. subcutaneous thigh and abdominal injections are considered

. I know you feel strongly about this, but part of my modus operandi is to look at the largest science model I can find for reference, to work with my doctors recommendations, to challenge science, and to do my own research. Having had more than my share of medical misdiagnosis I can become obsessive about research. Ithas served me very well to identify things that doctors overlooked and incorporate alternative method science, medication‘s and procedures. In the end, there may have been nothing causal linking my switching back to the abdominal wall and it may be about the hormones, the time of day and refining my process in the second year. we shall see! I have no problem being wrong. I want you to know that as well. And I appreciate the discussion.!